CBSE Class X exam cancelled

Class XII boards postponed | Remdesivir production to double

CBSE Class X exam cancelled

Grim milestone: 2 Lakh new cases

Tribune News Service

New Delhi, April 14

Amid the Covid surge, the government today decided to postpone the CBSE Class XII exams and cancel Class X exams and to double the production of antiviral injection Remdesivir.

The Education Ministry said: “The board exams for Class XII to be held from May 4 to June 14 are postponed. These exams will be held hereafter. The situation will be reviewed on June 1 by the board and the details will be shared subsequently. A notice of at least 15 days will be given before the start of the examinations”.

The decision was taken at a high-level meeting chaired by Prime Minister Narendra Modi with Education Minister Ramesh Pokhriyal and key officials.

Vaccine assurance

The govt is committed to ensuring adequate availability of vaccines. —PM at Governors’ meet

The result of Class X will be prepared on the basis of objective criterion to be devised by the board. “Any candidate who is not satisfied with the marks allocated to him/her will be given an opportunity to sit in an exam as and when the conditions are conducive to hold the exams,” Pokhriyal said.

As the daily Covid 19 cases hit a new peak of 2 lakh cases on Wednesday and the 24-hour fatality figure crossed 1,000 for the first time in six months, the government announced measures to double the production of antiviral injection Remdesivir even as seven local manufacturers of the drug volunteered to bring down the price from Rs 3,500 a vial. Short supplies of Remdesivir (a sought-after investigational drug allowed for hospitalised Covid patients on oxygen) have been reported in the country.

The Ministry of Chemicals and Fertilisers today said it was fast-tracking approvals for seven additional production sites for Remdesivir and would also use special economic zone units for the purpose. The Centre also made it clear that Remdesivir was not to be used for Covid patients with mild infections. The current installed capacity of the seven manufacturers of Remdesivir in India is 38.80 lakh vials per month. “Fast-track approval has been given for seven additional sites having the production capacity of 10 lakh vials a month. The production of another 30 lakh vials a month is lined up. This would ramp up the capacity for manufacturing to around 78 lakh vials per month,” the government said.

Review on June 1

CBSE to review situation for Class XII exams on June 1

LDCs support call to waive vax-related IPR

UN: The 46-member grouping of the Least Developed Countries has said it supports a request by India and S Africa to the WTO to suspend intellectual property rights for Covid vax to increase their access in these countries.

Short of med oxygen, Pb writes to Centre

Punjab has asked the Centre for additional supply of medical oxygen for critical Covid patients.

Top Stories

Could have saved many lives with door-to-door vaccination: Bombay High Court

Could have saved many lives with door-to-door vaccination: Bombay High Court

Court reiterates its April 22 order in which it asked Centre...

Covaxin recommended for trial on 2-18 age group

Covaxin recommended for trial on 2-18 age group

Trial will take place in AIIMS (Delhi), AIIMS (Patna) and Me...

HC seeks details from Punjab, Haryana about COVID situation in rural areas

HC seeks details from Punjab, Haryana about COVID situation in rural areas

Punjab needs about 4 lakh vials of Covishield vaccine immedi...

Photography, video recording prohibited at Central Vista construction site

Photography, video recording prohibited at Central Vista construction site

Govt facing criticism from opposition for executing Central ...

At 4,205, India reports record Covid deaths in a day

At 4,205, India reports record Covid deaths in a day

3,48,421 fresh cases reported

Cities

View All